HCWB HCW Biologics Inc
Company Analysis
Latest News
π’ HCW Biologics is trading 5.19% up today amid post-split dynamics and market strength
HCW Biologics is trading 5.19% up at $4.66 today amid post-split trading dynamics and broader market gains. β’ The stock's 1-for-6 reverse split became...
π’ HCWB is trading 6.3% up today as volatility persists following its 1-for-6 reverse split
HCWB is trading at $4.75 (6.3% up) in after-hours trading as investors continue to digest its recent 1-for-6 reverse split and Nasdaq bid-price compliance...
π΄ HCWB is trading 5.7% down today after 1-for-6 reverse split and Nasdaq compliance news
HCWB is trading at $4.36 (5.7% down) as traders digest its recent 1-for-6 reverse stock split and Nasdaq bid-price compliance news. β’ The stock has...
HCW Biologics Pulls the Reverse-Split Lever, but Can a Share-Price Reset Mask Deeper Trouble?
Shares of HCW Biologics surged in pre-market trading to $4.71, up 9.5% from the prior close of $4.30, as the micro-cap immunology company continues to whipsaw...
π’ HCWB is trading 9.5% up today after its 1-for-6 reverse stock split became effective
HCWB is trading at $4.71 (+9.53%) in pre-market after its 1-for-6 reverse stock split became effective on June 30, 2026. β’ The move follows a period of...
π΄ HCWB is trading 5% down today following its 1-for-6 reverse stock split and Nasdaq compliance update
HCWB is trading at $4.74 (5% down) as investors digest its June 30 one-for-six reverse stock split and Nasdaq bid-price compliance update. β’ The stock...
π’ HCWB makes sharp 11.2% jump
HCWB is trading at $5.55, up 11.2% versus the comparison close of $4.99 during after-hours. This is a price-movement alert; no separate company-specific...
π’ HCWB is trading 6% up today after reverse stock split and Nasdaq compliance
HCWB is trading at $5.29 (6% up) in after-hours trading after implementing a 1-for-6 reverse stock split and regaining Nasdaq bid-price compliance. β’ The...
π’ HCWB is trading 469.6% up today after regaining Nasdaq compliance via a 1-for-6 reverse stock split
HCWB is trading at $4.99, up 469.63% today after HCW Biologics regained Nasdaq bid-price compliance and implemented a 1-for-6 reverse stock split. β’ The...
π’ HCWB is trading 536.4% up today after regaining Nasdaq compliance via a 1-for-6 reverse split
HCWB is trading 536.4% up at $5.58 after implementing a 1-for-6 reverse stock split and confirming it has regained Nasdaq bid-price compliance for continued...
π’ HCWB is trading 8.45% up today after regaining Nasdaq compliance and announcing a 1-for-6 reverse split
HCWB is trading at $5.70 (8.45% up) after HCW Biologics announced it regained Nasdaq bid-price compliance and will execute a 1-for-6 reverse stock split. β’...
HCW Biologics Regains Nasdaq Compliance, Announces 1-for-6 Reverse Stock Split
HCW Biologics announced it has regained compliance with the Nasdaq's minimum bid price requirement, as confirmed by the Nasdaq Hearings Panel on June 29, 2026....
π’ HCW Biologics Inc is trading 9.58% up in after-hours
HCWB is trading at $0.96, up 9.58% in after-hours.
π΄ HCWB makes sharp 12.9% drop
HCWB is trading at $0.90, down 12.9% versus the comparison close of $1.03 during regular trading. This is a price-movement alert; no separate company-specific...
π΄ HCWB is trading 7.8% down today on a 1-for-6 reverse stock split announcement
HCWB is trading at $0.95 (7.8% down) as investors react to the company's recently announced 1-for-6 reverse stock split. β’ The reverse split, effective June...
π’ HCWB is trading 6.3% up today after announcing a 1-for-6 reverse stock split
HCWB is trading 6.3% up at $1.09 in pre-market after announcing a 1-for-6 reverse stock split effective June 30, 2026. β’ The corporate action, detailed in a...
HCWB's Second Reverse Split in 14 Months: Can a Clinical-Stage Biotech Survive on Financial Engineering Alone?
Shares of HCW Biologics dropped 15.2% to $0.95 after the company announced its board approved a 1-for-6 reverse stock split, effective June 30, 2026 β the...
π΄ HCWB is trading 15% down today after announcing a 1-for-6 reverse split for Nasdaq compliance
HCWB is trading 15% down at $0.95 after its Board approved a 1-for-6 reverse stock split aimed at maintaining compliance with Nasdaqβs $1.00 minimum bid price...
HCW Biologics Announces 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing
HCW Biologics Inc. (HCWB) announced its Board of Directors has approved a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. This action...
π΄ HCWB Plunges 23.9% After Announcing 1-for-6 Reverse Stock Split
HCWB is trading at $0.85 (23.9% down) after HCW Biologics announced a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. β’ The reverse...